Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis

Silvia Corrochano, Roope Männikkö, Peter I Joyce, Philip McGoldrick, Jessica Wettstein, Glenda Lassi, Dipa L Raja Rayan, Gonzalo Blanco, Colin Quinn, Andrianos Liavas, Arimantas Lionikas, Neta Amior, James Dick, Estelle G Healy, Michelle Stewart, Sarah Carter, Marie Hutchinson, Liz Bentley, Pietro Fratta, Andrea CorteseRoger Cox, Steve D M Brown, Valter Tucci, Henning Wackerhage, Anthony A Amato, Linda Greensmith, Martin Koltzenburg, Michael G Hanna, Abraham Acevedo-Arozena

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)
9 Downloads (Pure)


Mutations in the skeletal muscle channel (SCN4A), encoding the Nav1.4 voltage-gated sodium channel, are causative of a variety of muscle channelopathies, including non-dystrophic myotonias and periodic paralysis. The effects of many of these mutations on channel function have been characterized both in vitro and in vivo. However, little is known about the consequences of SCN4A mutations downstream from their impact on the electrophysiology of the Nav1.4 channel. Here we report the discovery of a novel SCN4A mutation (c.1762A>G; p.I588V) in a patient with myotonia and periodic paralysis, located within the S1 segment of the second domain of the Nav1.4 channel. Using N-ethyl-N-nitrosourea mutagenesis, we generated and characterized a mouse model (named draggen), carrying the equivalent point mutation (c.1744A>G; p.I582V) to that found in the patient with periodic paralysis and myotonia. Draggen mice have myotonia and suffer from intermittent hind-limb immobility attacks. In-depth characterization of draggen mice uncovered novel systemic metabolic abnormalities in Scn4a mouse models and provided novel insights into disease mechanisms. We discovered metabolic alterations leading to lean mice, as well as abnormal AMP-activated protein kinase activation, which were associated with the immobility attacks and may provide a novel potential therapeutic target.

Original languageEnglish
Pages (from-to)3171-3185
Number of pages15
Issue number12
Publication statusPublished - Dec 2014

Bibliographical note

© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

We thank the MRC Mary Lyon Centre (Ward 6 and Sara Wells) and MRC Harwell GEMS, necropsy and histology teams for excellent technical support. We thank Dr Charlotte Dean for the analysis of neonatal lungs, Dr Karen Suetterlin and Dr Alison Landman for critical reading of the manuscript.

This study was supported by a Medical Research Council programme grant to SDMB and A A-A.


  • SCN4A
  • mice
  • AMPK
  • periodic paralysis
  • myotonia


Dive into the research topics of 'Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis'. Together they form a unique fingerprint.

Cite this